Debra Yu (LianBio)
Pfizer hands LianBio $70M to tag along Perceptive's China play, with an eye to beefing up regional portfolio
When Perceptive unveiled its carefully curated syndicate for LianBio’s $310 million Series A, Pfizer stood out as the only pharma amid a marquee group …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.